Published in:
Open Access
01-03-2021 | Hydrocephalus | Editorial (by Invitation)
Predicting the outcome of normal pressure hydrocephalus therapy—where do we stand?
Authors:
Joachim M. K. Oertel, Matthias J. M. Huelser
Published in:
Acta Neurochirurgica
|
Issue 3/2021
Login to get access
Excerpt
Normal-pressure hydrocephalus (NPH) is a treatable disease. It is the only form of dementia for which we do have effective treatment modalities. Permanent cerebrospinal fluid diversion via shunt insertion is the gold standard. The objective response to the shunt treatment is about 85% [
6], at least for a certain time. The majority of patients (85 %) respond to this treatment, but what about the other 15%? How can we predict which patient will respond to treatment and who will not? …